Cargando…
Early immunologic response to mRNA COVID-19 vaccine in patients receiving biologics and/or immunomodulators
Patients with immune conditions and immune-modifying therapies were excluded from the Covid-19 vaccine trials. Studies have shown conflicting response to different vaccines in persons receiving immune suppressors or biologics. The aim of this study is to evaluate humoral and cellular response to Cov...
Autores principales: | Rodríguez-Martinó, Esteban, Medina-Prieto, Rafael, Santana-Bagur, Jorge, Santé, María, Pantoja, Petraleigh, Espino, Ana M., Sariol, Carlos A., Torres, Esther A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452103/ https://www.ncbi.nlm.nih.gov/pubmed/34545370 http://dx.doi.org/10.1101/2021.09.11.21263211 |
Ejemplares similares
-
Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose
por: López-Marte, Paola, et al.
Publicado: (2022) -
Limited impact of Delta variant’s mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population
por: Sariol, Carlos A., et al.
Publicado: (2021) -
Limited Impact of Delta Variant’s Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population
por: Sariol, Carlos A., et al.
Publicado: (2021) -
Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
por: Albarnaz, Jonas D., et al.
Publicado: (2018) -
Immunological monitoring in ICU patients: immunomodulation for compromised host
por: Takeyama, N, et al.
Publicado: (2001)